Zoic Capital Revenue and Competitors
Estimated Revenue & Valuation
- Zoic Capital's estimated annual revenue is currently $1M per year.
- Zoic Capital's estimated revenue per employee is $84,000
Employee Data
- Zoic Capital has 12 Employees.
- Zoic Capital grew their employee count by 0% last year.
Zoic Capital's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Due Diligence | Reveal Email/Phone |
2 | Partner, Managing Director | Reveal Email/Phone |
3 | Venture Partner | Reveal Email/Phone |
4 | Partner, Head IP | Reveal Email/Phone |
5 | Partner | Reveal Email/Phone |
Zoic Capital Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 17 | 0% | N/A | N/A |
#2 | $3.5M | 31 | -11% | N/A | N/A |
#3 | $2.5M | 26 | 0% | N/A | N/A |
#4 | $1M | 12 | 0% | N/A | N/A |
#5 | $4.3M | 38 | -10% | N/A | N/A |
#6 | $0.6M | 9 | -36% | N/A | N/A |
#7 | $4.7M | 42 | 8% | N/A | N/A |
#8 | $1.6M | 19 | N/A | N/A | N/A |
#9 | $2.1M | 21 | 11% | N/A | N/A |
#10 | $1.3M | 16 | N/A | N/A | N/A |
What Is Zoic Capital?
Zoic Capital is the only US-based venture firm focused on early stage healthcare innovations at the intersection of life sciences and medical technology. Promising Scientific Advancements: We look for breakthroughs with the potential for broad IP and commercial-ready maturity. We invest in roadmaps that leverage a core innovation across many applications and industries. Focus on Life Sciences: We see the most exciting advancements coming from life sciences labs, becoming tools that maintain and treat our health. We look at both technologies that enable development and care delivery devices. We Follow the Numbers: We follow our gut, but we also reinforce each of our decisions with numbers. We believe that merging qualitative and quantitative analysis is the best way to make successful investment decisions. Mentored Capital: We have the skills, experience and network to help, working closely with select teams to transform research into high impact, market-ready products. Milestone-Based Investing: We craft unique deal structures for each portfolio company based on mutually defined milestones. We find this approach creates ongoing momuntum and sets us all up for success.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 12 | -8% | N/A |
#2 | $1.8M | 12 | -57% | N/A |
#3 | $1M | 12 | -14% | N/A |
#4 | $1M | 12 | N/A | N/A |
#5 | $1M | 12 | 33% | N/A |